74 related articles for article (PubMed ID: 11551028)
1. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy.
Dvorak HF
J Clin Oncol; 2002 Nov; 20(21):4368-80. PubMed ID: 12409337
[TBL] [Abstract][Full Text] [Related]
2. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (HDR) brachytherapy of liver metastases.
Damm R; Pech M; Cavalli P; Haag F; Gylstorff S; Omari J; Thormann M; Seidensticker R; Ricke J; Seidensticker M; Relja B
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2815-2826. PubMed ID: 35596772
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-Induced Liver Injury in Patients with Colorectal Liver Metastases: Findings from MR Imaging.
Donati F; Cioni D; Guarino S; Mazzeo ML; Neri E; Boraschi P
Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453915
[TBL] [Abstract][Full Text] [Related]
4. Cellular Conversations in Glioblastoma Progression, Diagnosis and Treatment.
Sisakht AK; Malekan M; Ghobadinezhad F; Firouzabadi SNM; Jafari A; Mirazimi SMA; Abadi B; Shafabakhsh R; Mirzaei H
Cell Mol Neurobiol; 2023 Mar; 43(2):585-603. PubMed ID: 35411434
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Ganoderma Microsporum immunomodulatory proteins on alleviating PM
Tseng CY; Yu JY; Chuang YC; Lin CY; Wu CH; Liao CW; Yang FH; Chao MW
Sci Rep; 2019 May; 9(1):6854. PubMed ID: 31048730
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab exacerbates sinusoidal obstruction syndrome (SOS) in the animal model and increases MMP 9 production.
Jafari A; Matthaei H; Wehner S; Tonguc T; Kalff JC; Manekeller S
Oncotarget; 2018 Apr; 9(31):21797-21810. PubMed ID: 29774103
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of thromboelastometry parameters as predictive markers for sinusoidal obstruction syndrome in patients undergoing allogeneic stem cell transplantation for acute leukaemia.
Rupa-Matysek J; Gil L; Wojtasińska E; Kanduła Z; Nowicki A; Matuszak M; Komarnicki M
Oncotarget; 2017 Aug; 8(35):60001-60014. PubMed ID: 28938703
[TBL] [Abstract][Full Text] [Related]
8. Splenomegaly and Its Associations with Genetic Polymorphisms and Treatment Outcome in Colorectal Cancer Patients Treated with Adjuvant FOLFOX.
Kim MJ; Han SW; Lee DW; Cha Y; Lee KH; Kim TY; Oh DY; Kim SH; Im SA; Bang YJ; Kim TY
Cancer Res Treat; 2016 Jul; 48(3):990-7. PubMed ID: 26790967
[TBL] [Abstract][Full Text] [Related]
9. Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy: Potential Markers for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome.
Park S; Kim HY; Kim H; Park JH; Kim JH; Kim KH; Kim W; Choi IS; Jung YJ; Kim JS
Medicine (Baltimore); 2016 Jan; 95(2):e2454. PubMed ID: 26765438
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy.
Nishigori N; Matsumoto M; Koyama F; Hayakawa M; Hatakeyayama K; Ko S; Fujimura Y; Nakajima Y
PLoS One; 2015; 10(11):e0143136. PubMed ID: 26580395
[TBL] [Abstract][Full Text] [Related]
11. Sinusoidal obstruction syndrome (hepatic veno-occlusive disease).
Fan CQ; Crawford JM
J Clin Exp Hepatol; 2014 Dec; 4(4):332-46. PubMed ID: 25755580
[TBL] [Abstract][Full Text] [Related]
12. A Reappraisal of Chemotherapy-Induced Liver Injury in Colorectal Liver Metastases before the Era of Antiangiogenics.
Nguyen-Khac E; Lobry C; Chatelain D; Fuks D; Joly JP; Brevet M; Tramier B; Mouly C; Hautefeuille V; Chauffert B; Regimbeau JM
Int J Hepatol; 2013; 2013():314868. PubMed ID: 23533786
[TBL] [Abstract][Full Text] [Related]
13. Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases.
Li DB; Ye F; Wu XR; Wu LP; Chen JX; Li B; Zhou YM
World J Gastroenterol; 2013 Feb; 19(5):761-8. PubMed ID: 23431050
[TBL] [Abstract][Full Text] [Related]
14. Colorectal liver metastases.
Haddad AJ; Bani Hani M; Pawlik TM; Cunningham SC
Int J Surg Oncol; 2011; 2011():285840. PubMed ID: 22312501
[TBL] [Abstract][Full Text] [Related]
15. Successful reduced-intensity SCT from unrelated cord blood in three patients with X-linked SCID.
Iguchi A; Kawamura N; Kobayashi R; Takezaki SI; Ohkura Y; Inamoto J; Ohshima J; Ichikawa M; Sato T; Kaneda M; Cho Y; Yamada M; Kobayashi I; Ariga T
Bone Marrow Transplant; 2011 Dec; 46(12):1526-31. PubMed ID: 21258424
[TBL] [Abstract][Full Text] [Related]
16. Advances in therapeutics for liver metastasis from colorectal cancer.
Kobayashi A; Miyagawa S
World J Gastrointest Oncol; 2010 Oct; 2(10):380-9. PubMed ID: 21160889
[TBL] [Abstract][Full Text] [Related]
17. Prediction of veno-occlusive disease using biomarkers of endothelial injury.
Cutler C; Kim HT; Ayanian S; Bradwin G; Revta C; Aldridge J; Ho V; Alyea E; Koreth J; Armand P; Soiffer R; Ritz J; Richardson PG; Antin JH
Biol Blood Marrow Transplant; 2010 Aug; 16(8):1180-5. PubMed ID: 20184961
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of glutathione S-transferase A1-1 in ECV 304 cells protects against busulfan mediated G2-arrest and induces tissue factor expression.
Ritter CA; Sperker B; Grube M; Dressel D; Kunert-Keil C; Kroemer HK
Br J Pharmacol; 2002 Dec; 137(7):1100-6. PubMed ID: 12429583
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation.
Iguchi A; Kobayashi R; Yoshida M; Kobayashi K; Matsuo K; Kitajima I; Maruyama I
Bone Marrow Transplant; 2001 Jun; 27(11):1173-80. PubMed ID: 11551028
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
